Microbot’s stock rockets on heavy volume after collaboration pact with Stryker on robotic procedural kits

- Advertisement -


MBOT, shares of Microbot Medical Inc.
+7.11%
After the pre-clinical medical device company announced a deal with Stryker Corp. SYK, the pre-clinical medical device company gained 67.3% in premarket trading on Monday, towards a nine-month high, with massive volumes.
+1.59%
Developing the first dedicated robotic procedural kit for use in certain neurovascular procedures. Trading volume increased to 9.6 million shares compared to the full day average of around 49,000 shares. The stock was the biggest gainer and was most actively traded at the open. As part of the agreement, Microbot’s Liberty robotic system will integrate with Stryker’s neurovascular devices. “We have already made sure that Liberty Robotic Systems has a strong and sustainable competitive advantage, and the collaboration with Stryker will allow us to further expand into the neurovascular space,” said Microbot Chief Executive Harel Gadot. The stock, which was on track to open at the highest price seen during regular-session hours since March 2021, has fallen 23.5% in the past three months since Thursday, while the S&P 500 SPX,
+0.62%
increased by 6.4%.

- Advertisement -

,

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox